Home › Overweight › North Carolina

Pag-aaral pangklinika para sa Overweight sa North Carolina

40 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

Centricity Research, Morehead City

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07871409

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Statesville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07776509

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Centricity Research Morehead City Multispeciality, Morehead City
Wake Forest University Health Sciences, Winston-Salem

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07351058

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Centricity Research Morehead City Specialty, Morehead City
Accellacare of Raleigh, Raleigh
Accellacare Research of Wilmington, Wilmington

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07575399

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

Medication Management, LLC, Greensboro
Monroe Biomedical Research, Monroe
Accellacare - Wilmington, Wilmington

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07845500

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

Novant Health Granite Quarry Internal Medicine (knee x-ray), Granite Quarry
Monroe Biomedical Research, Monroe
Accellacare - Salisbury, Salisbury
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Medication Management, Greensboro
Monroe Biomedical Research, Monroe
West Clinical Research, Morehead City
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Medication Management, LLC, Greensboro
Accellacare - Wilmington, Wilmington
Jeffrey Coleman, OD, Wilmington

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07595549

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Revival Research Institute, LLC, Cary
Onsite Clinical Solutions - Huntersville, Huntersville

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06857942

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

PharmQuest Life Sciences, LLC, Greensboro
West Clinical Research, Morehead City
Trial Management Associates - Wilmington - Floral Parkway, Wilmington

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

University of North Carolina Medical Center, Chapel Hill
Medication Management, Greensboro
Carteret Medical Group, Morehead City
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07392190

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Coastal Research Institute - Fayetteville, Fayetteville

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Coastal Research Institute - Fayetteville, Fayetteville

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06937086

A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)

Carolina Research Center, Shelby

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07915609

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

UNC Children's Hospital, Chapel Hill
Duke Children's Primary Care, Durham
Lucas Research, Inc, Morehead City

Nagre-recruitPhase 3

Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06672549

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Lucas Research, Inc., Morehead City
Shelby Clinical Research, Shelby

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06897475

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Rocky Mount
Research Site, Statesville
Research Site, Wilmington

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Monroe

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07784270

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Medication Management /ID# 281965, Greensboro
Monroe Biomedical Research /ID# 282009, Monroe
Centricity Research - Morehead city /ID# 283264, Morehead City
at 2 pa

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07752979

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

TMA Headlands, Wilmington

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07837973

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Charlotte
ACCOMPLISH-2 Research Site, Durham
ACCOMPLISH-2 Research Site, Fayetteville
at 2 pa

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07654374

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Monroe Biomedical Research, LLC, Monroe
PHC Accelacare, Statesville
Accellacare, Wilmington

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07607587

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Medication Management, Greensboro
Monroe Biomedical Research, Monroe
Lucas Research, Inc, Morehead City
at 1 pa

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Medication Management, Greensboro
Monroe Biomedical Research, Monroe
Lucas Research, Inc, Morehead City
at 1 pa

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Accellacare of Hickory, Hickory
Carolina Research Center Inc, Shelby

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

West Clinical Research, Morehead City

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684144

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

University of North Carolina at Chapel Hill, Chapel Hill

Nagre-recruit

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06724406

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Medication Mgmnt, LLC_Grnsboro, Greensboro
Accellacare of Raleigh, Raleigh
Accellacare-Salisbury PMG Res, Salisbury
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

PharmQuest Life Sciences LLC, Greensboro
Piedmont Healthcare/Research, Statesville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07668414

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Monroe Biomedical Research, Monroe

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07321886

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Charlotte
AURORA-2 Clinical Site, Durham
AURORA-2 Clinical Site, Greenville
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Charlotte
AURORA-1 Clinical Site, Greenville
AURORA-1 Clinical Site, Morehead City
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

PharmQuest, Greensboro
KDCILM, LLC & Accellacare US, Inc., Wilmington

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07745504

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Piedmont Healthcare/Research, Statesville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Charlotte
ACCOMPLISH-1 Research Site, Durham
ACCOMPLISH-1 Research Site, Fayetteville
at 3 pa

Nagre-recruitPhase 3

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

Monroe Biomedical Research, Monroe

Nagre-recruitPhase 2

Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT07570758

Pregnancy Exercise Mode Effect on Childhood Obesity

East Carolina University, Greenville

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 45 · Kababaihan · Na-update Hun 4, 2026 · NCT04805502

NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

Wake Forest University Health Sciences, Winston-Salem

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 39 · Kababaihan · Na-update Peb 27, 2026 · NCT05674799

A Mobile Intervention to Reduce Pain and Improve Health-III

Wake Forest University, Winston-Salem

Nagre-recruitPhase 2

Edad 65 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT06623669

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

True You Weight Loss, Cary
True You Weight Loss, Cary

Nagre-recruit

Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Mar 21, 2025 · NCT06734312

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.